ClearBridge Investments
LXRX icon

ClearBridge Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

ClearBridge Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,463,262
Closed -$9.2M – 1124
2019
Q2 		$9.2M Buy
1,463,262
+171,132
+13% +$1.02M 0.01% 539
2019
Q1 		$7.18M Buy
1,292,130
+42,540
+3% +$258K 0.01% 554
2018
Q4 		$8.3M Sell
1,249,590
-46,320
-4% -$375K 0.01% 547
2018
Q3 		$13.8M Buy
1,295,910
+1,295,777
+974,268% +$14.8M 0.01% 503
2018
Q2 		$2K Buy
133
+11
+9% +$113 ﹤0.01% 1095
2018
Q1 		$1K Hold
122
– – ﹤0.01% 1139
2017
Q4 		$1K Sell
122
-2,432
-95% -$25.3K ﹤0.01% 1148
2017
Q3 		$31K Buy
2,554
+305
+14% +$4.5K ﹤0.01% 968
2017
Q2 		$37K Buy
2,249
+412
+22% +$6.38K ﹤0.01% 903
2017
Q1 		$26K Buy
+1,837
New +$27.3K ﹤0.01% 970

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return